Stock Research: SCHOTT Pharma AG & Co

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

SCHOTT Pharma AG & Co

GER:1SXP DE000A3ENQ51
33
  • Value
    67
  • Growth
    1
  • Safety
    Safety
    86
  • Combined
    42
  • Sentiment
    28
  • 360° View
    360° View
    33
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description
Index
CDAX
SDAX
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
67 n/a n/a n/a
Growth
1 n/a n/a n/a
Safety
Safety
86 n/a n/a n/a
Sentiment
28 n/a n/a n/a
360° View
360° View
33 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
11 n/a n/a n/a
Opinions Change
17 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
86 n/a n/a n/a
Sentiment
28 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
67 n/a n/a n/a
Growth
1 n/a n/a n/a
Safety Safety
86 n/a n/a n/a
Combined
42 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
59 n/a n/a n/a
Price vs. Earnings (P/E)
50 n/a n/a n/a
Price vs. Book (P/B)
76 n/a n/a n/a
Dividend Yield
53 n/a n/a n/a
Value
67 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
38 n/a n/a n/a
Profit Growth
27 n/a n/a n/a
Capital Growth
23 n/a n/a n/a
Stock Returns
13 n/a n/a n/a
Growth
1 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
75 n/a n/a n/a
Refinancing
49 n/a n/a n/a
Liquidity
85 n/a n/a n/a
Safety Safety
86 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to SCHOTT Pharma AG & Co and broaden your portfolio horizons.

KSB

GER:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Krka

LJU:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

ALSO

SWX:ALSN
Country: Germany
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

n/a

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: